Sort
46,585 grants matching “heart failure”
New method to treat or prevent corneal graft rejection
$410,813Qingguo Xu · Virginia Commonwealth University · R01 · FY2017 · EY
Periodontal Disease and Coronary Artery Remodeling in CHD and Metabolic Syndrome
$410,791Francine K Welty · Beth Israel Deaconess Medical Center · R01 · FY2011 · DE
Theory Assisted Design, Synthesis and Biological Activity of Bacteria-Targeting Nanostructures
$410,713Martin Miguel Conda Sheridan · University Of Nebraska Medical Center · R01 · FY2025 · EB
PET Imaging of Thrombus
$410,708Peter D Caravan · Massachusetts General Hospital · R01 · FY2019 · HL
Molecular basis for the regulation of G protein-coupled receptor kinases
$410,702John J G Tesmer · University Of Michigan At Ann Arbor · R01 · FY2012 · HL
Effectiveness of treat-to-target versus risk-based blood pressure guidelines
$410,697Andrew Edward Moran · Columbia University Health Sciences · R01 · FY2013 · HL
Genetic association in schizophrenia and other disorders
$410,683Bernie Devlin · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · MH
Proteasome, protein oxidation, and cardiomyocyte function.
$410,661Saul R Powell · Feinstein Institute For Medical Research · R01 · FY2011 · HL
Biasing Myocardial Neuregulin Signaling with Engineered Ligands
$410,653Richard T Lee · Brigham And Women'S Hospital · R01 · FY2014 · HL
Cellular Biology of Cardiac Sodium-Calcium Exchange
$410,634Joshua I Goldhaber · Cedars-Sinai Medical Center · R01 · FY2013 · HL
Nitric oxide synthase 3 and left ventricular remodeling
$410,600Massachusetts General Hospital · R01 · FY2005 · HL
Nitric oxide synthase 3 and left ventricular remodeling
$410,600Massachusetts General Hospital · R01 · FY2004 · HL
Human Senescence and Cardioprotection
$410,597Arshad Jahangir · Mayo Clinic Arizona · R01 · FY2009 · HL
RIGHT VENTRICULO-PULMONARY VASCULAR COUPLING IN PAH
$410,523David Alan Kass · Johns Hopkins University · P50 · FY2008 · HL
Inconspicuous Daily Monitoring to Reduce Heart Failure Hospitalizations
$410,482Linwei Wang · Rochester Institute Of Technology · R01 · FY2021 · NR
In Vivo Measurement of Myocardial Oxygen Consumption
$410,459Massachusetts General Hospital · R01 · FY2002 · HL
Characterizing the Sensory and Affective Neural Components of Persistent Dyspnea
$410,448Jose Luis Herrero Rubio · Feinstein Institute For Medical Research · R01 · FY2024 · HL
A Test for Salt Sensitivity in People with Essential Hypertension
$410,387Stephen L Carrithers · Sequela · R44 · FY2009 · DK
SUSCEPTIBILITY TO HYPERTENSIVE TARGET ORGAN DAMAGE
$410,350Loyola University Chicago · R01 · FY2000 · HL
Metabolic Reprogramming of the Adult heart to a Regenerative State
$410,290Ahmed I Mahmoud · University Of Wisconsin-Madison · R01 · FY2024 · HL
Non-Invasive Multi-Modal Neuromonitoring in Adults Undergoing Extracorporeal Membrane Oxygenation
$410,278Regine Choe · University Of Rochester · R01 · FY2025 · NS
Regulation of Beta Adrenergic Receptor Function by localized P13K Inhibition
$410,267Howard A Rockman · Duke University · P01 · FY2008 · HL
Cardiac Conduction through Engineered Tissue
$410,248Douglas B. Cowan · Boston Children'S Hospital · R01 · FY2008 · HL
Cardiac Conduction through Engineered Tissue
$410,248Douglas B. Cowan · Boston Children'S Hospital · R01 · FY2007 · HL
Cardiac Conduction through Engineered Tissue
$410,248Douglas B. Cowan · Boston Children'S Hospital · R01 · FY2009 · HL